{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T06:31:23Z","timestamp":1766557883582},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T00:00:00Z","timestamp":1410393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00223-014-9908-x","type":"journal-article","created":{"date-parts":[[2014,9,10]],"date-time":"2014-09-10T02:47:29Z","timestamp":1410317249000},"page":"405-412","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Identifying Atypical Femoral Fractures\u2014A Retrospective Review"],"prefix":"10.1007","volume":"95","author":[{"given":"Angela G.","family":"Juby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Crowther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Cree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,11]]},"reference":[{"key":"9908_CR1","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1210\/jc.2010-1571","volume":"95","author":"B Abrahamsen","year":"2010","unstructured":"Abrahamsen B, Eiken P, Eastell R (2010) Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis. J Clin Endocrinol Metab 95:5258\u20135265","journal-title":"J Clin Endocrinol Metab"},{"key":"9908_CR2","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.clinthera.2011.09.006","volume":"33","author":"FY Hsiao","year":"2011","unstructured":"Hsiao FY, Huang WF, Chen YM et al (2011) Hip and subtrochanteric or diaphyseal femoral fractures in alendronate users: a 10-year, nationwide retrospective cohort study in Taiwanese women. Clin Ther 33:1659\u20131667","journal-title":"Clin Ther"},{"key":"9908_CR3","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMc0707493","volume":"358","author":"BA Lenart","year":"2008","unstructured":"Lenart BA, Lorich DG, Lane JM (2008) Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 358:1304\u20131306","journal-title":"N Engl J Med"},{"key":"9908_CR4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00003086-200003000-00026","volume":"372","author":"ST Salminen","year":"2000","unstructured":"Salminen ST, Pihlajam\u00e4ki HK, Avikainen VJ, B\u00f6stman OM (2000) Population based epidemiologic and morphologic study of femoral shaft fractures. Clin Orthop Relat Res 372:241\u2013249","journal-title":"Clin Orthop Relat Res"},{"key":"9908_CR5","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00198-008-0805-x","volume":"20","author":"BA Lenart","year":"2009","unstructured":"Lenart BA, Neviaser AS, Lyman S et al (2009) Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int 20:1353\u20131362","journal-title":"Osteoporos Int"},{"key":"9908_CR6","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","volume":"25","author":"E Shane","year":"2010","unstructured":"Shane E, Burr D, Ebeling PR et al (2010) Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 25:2267\u20132294","journal-title":"J Bone Miner Res"},{"key":"9908_CR7","author":"E Shane","year":"2013","unstructured":"Shane E, Burr D, Abrahamsen B et al (2013) Atypical subtrochanteric and diaphyseal femoral fractures: second Report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. doi: 10.1002\/jbmr.1998","journal-title":"J Bone Miner Res"},{"key":"9908_CR8","unstructured":"http:\/\/www.proliahcp.com\/safety-profile\/"},{"issue":"3","key":"9908_CR9","doi-asserted-by":"crossref","first-page":"e64-8","DOI":"10.4158\/EP12367.CR","volume":"19","author":"R Paparodis","year":"2013","unstructured":"Paparodis R, Buehring B, Pelley EM, Binkley N (2013) A case of an unusual subtrochanteric fracture in a patient receiving denosumab. Endocr Pract 19(3):e64-8","journal-title":"Endocr Pract"},{"key":"9908_CR10","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1010650","volume":"364","author":"J Schilcher","year":"2011","unstructured":"Schilcher J, Michaelsson K, Aspenberg P (2011) Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 364:1728\u20131737","journal-title":"N Engl J Med"},{"key":"9908_CR11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jama.2011.190","volume":"305","author":"LY Park-Wyllie","year":"2011","unstructured":"Park-Wyllie LY, Mamdani MM, Juurlink DN et al (2011) Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA 305:783\u2013789","journal-title":"JAMA"},{"key":"9908_CR12","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa1001086","volume":"362","author":"DM Black","year":"2010","unstructured":"Black DM, Kelly MP, Genant HK et al (2010) Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med 362:1761\u20131771","journal-title":"N Engl J Med"},{"key":"9908_CR13","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/jbmr.288","volume":"26","author":"SY Kim","year":"2011","unstructured":"Kim SY, Schneeweiss S, Katz JN et al (2011) Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort. J Bone Miner Res 26:993\u20131001","journal-title":"J Bone Miner Res"},{"key":"9908_CR14","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/jbmr.1550","volume":"27","author":"AC Feldstein","year":"2012","unstructured":"Feldstein AC, Black D, Perrin N et al (2012) Incidence and demography of femur fractures with and without atypical features. J Bone Miner Res 27:977\u2013986","journal-title":"J Bone Miner Res"},{"key":"9908_CR15","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.bone.2010.12.033","volume":"48","author":"A Giusti","year":"2011","unstructured":"Giusti A, Hamdy NA, Dekkers OM et al (2011) Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features. Bone 48:966\u2013971","journal-title":"Bone"},{"issue":"2","key":"9908_CR16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jbspin.2012.07.012","volume":"80","author":"C Beaudouin-Bazire","year":"2013","unstructured":"Beaudouin-Bazire C, Dalmas N, Bourgeois J et al (2013) Real frequency of ordinary and atypical sub-trochanteric and diaphyseal fractures in France based on X-rays and medical file analysis. Joint Bone Spine 80(2):201\u2013205","journal-title":"Joint Bone Spine"},{"key":"9908_CR17","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s00198-010-1476-y","volume":"22","author":"L Spangler","year":"2011","unstructured":"Spangler L, Ott SM, Scholes D (2011) Utility of automated data in identifying femoral shaft and subtrochanteric (diaphyseal) fractures. Osteoporos Int 22:2523\u20132527","journal-title":"Osteoporos Int"},{"issue":"12","key":"9908_CR18","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/jbmr.1719","volume":"27","author":"RM Dell","year":"2012","unstructured":"Dell RM, Adams AL, Greene DF, Funahashi TT, Silverman SL, Eisemon EO, Zhou H, Burchette RJ, Ott SM (2012) Incidence of atypical nontraumatic diaphyseal fractures of the femur. J Bone Miner Res 27(12):2544\u20132550","journal-title":"J Bone Miner Res"},{"key":"9908_CR19","author":"L Gedmintas","year":"2013","unstructured":"Gedmintas L, Solomon DH, Kim SC (2013) Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis. J Bone Miner Res. doi: 10.1002\/jbmr.1893","journal-title":"J Bone Miner Res"},{"issue":"12","key":"9908_CR20","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archinternmed.2012.1796","volume":"172","author":"RP Meier","year":"2012","unstructured":"Meier RP, Perneger TV, Stern R, Rizzoli R, Peter RE (2012) Increasing occurrence of atypical femoral fractures associated with bisphosphonate use. Arch Intern Med 172(12):930\u2013936","journal-title":"Arch Intern Med"},{"issue":"1","key":"9908_CR21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bone.2012.10.016","volume":"52","author":"J Schilcher","year":"2013","unstructured":"Schilcher J, Koeppen V, Ranstam J, Skripitz R, Micha\u00eblsson K, Aspenberg P (2013) Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls. Bone 52(1):389\u2013392","journal-title":"Bone"},{"issue":"3","key":"9908_CR22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-009-0962-6","volume":"21","author":"JW Nieves","year":"2010","unstructured":"Nieves JW, Bilezikian JP, Lane JM et al (2010) Fragility fractures of the hip and femur: incidence and patient characteristics. Osteoporos Int 21(3):399\u2013408","journal-title":"Osteoporos Int"},{"key":"9908_CR23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jbmr.233","volume":"26","author":"Z Wang","year":"2011","unstructured":"Wang Z, Bhattacharyya T (2011) Trends in incidence of subtrochanteric fragility fractures and bisphosphonate use among the US elderly, 1996\u20132007. J Bone Miner Res 26:553\u2013560","journal-title":"J Bone Miner Res"},{"key":"9908_CR24","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00198-011-1777-9","volume":"23","author":"AC Ng","year":"2012","unstructured":"Ng AC, Drake MT, Clarke BL et al (2012) Trends in subtrochanteric, diaphyseal, and distal femur fractures, 1984\u20132007. Osteoporos Int 23:1721\u20131726","journal-title":"Osteoporos Int"},{"issue":"1","key":"9908_CR25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00198-012-1994-x","volume":"24","author":"B Abrahamsen","year":"2013","unstructured":"Abrahamsen B (2013) Are long-term bisphosphonate users a reality? Dose years for current bisphosphonate users assessed using the Danish national prescription database. Osteoporos Int 24(1):369\u2013372","journal-title":"Osteoporos Int"},{"issue":"8","key":"9908_CR26","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00198-006-0322-8","volume":"18","author":"JA Cramer","year":"2007","unstructured":"Cramer JA, Gold DT, Silverman SL, Lewiecki EM (2007) A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 18(8):1023\u20131031","journal-title":"Osteoporos Int"},{"issue":"3","key":"9908_CR27","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00198-011-1645-7","volume":"23","author":"AM Burden","year":"2012","unstructured":"Burden AM, Paterson JM, Solomon DH, Mamdani M, Juurlink DN, Cadarette SM (2012) Bisphosphonate prescribing, persistence and cumulative exposure in Ontario Canada. Osteoporos Int 23(3):1075\u20131082","journal-title":"Osteoporos Int"},{"key":"9908_CR28","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2106\/JBJS.J.01199","volume":"93","author":"ME Puhaindran","year":"2011","unstructured":"Puhaindran ME, Farooki A, Steensma MR, Hameed M, Healey JH, Boland PJ (2011) Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates. J Bone Joint Surg Am 93:1235\u20131242","journal-title":"J Bone Joint Surg Am"},{"key":"9908_CR29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/ebm.2011.000013","volume":"16","author":"B Abrahamsen","year":"2011","unstructured":"Abrahamsen B (2011) Older women who use bisphosphonate for longer than 5\u00a0years may have increased odds of a subtrochanteric or femoral shaft fracture, but absolute risk is low. Evid Based Med 16:168\u2013169","journal-title":"Evid Based Med"},{"issue":"22","key":"9908_CR30","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1056\/NEJMp1202623","volume":"366","author":"DM Black","year":"2012","unstructured":"Black DM, Bauer DC, Schwartz AV et al (2012) Continuing bisphosphonate treatment for osteoporosis\u2014for whom and for how long? N Engl J Med 366(22):2051\u20132053","journal-title":"N Engl J Med"},{"issue":"2","key":"9908_CR31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00198-008-0813-x","volume":"20","author":"E Seeman","year":"2009","unstructured":"Seeman E (2009) To stop or not to stop, that is the question. Osteoporos Int 20(2):187\u2013195","journal-title":"Osteoporos Int"},{"issue":"11","key":"9908_CR32","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00198-008-0604-4","volume":"19","author":"JR Curtis","year":"2008","unstructured":"Curtis JR, Westfall AO, Cheng H, Delzell E, Saag KG (2008) Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday. Osteoporos Int 19(11):1613\u20131620","journal-title":"Osteoporos Int"},{"key":"9908_CR33","doi-asserted-by":"crossref","unstructured":"Yli-Kyyny T (2011) Bisphosphonates and Atypical fracture. J Osteoporos. doi: 10.4061\/2011\/754972","DOI":"10.4061\/2011\/754972"},{"key":"9908_CR34","first-page":"324","volume":"60","author":"JP Brown","year":"2014","unstructured":"Brown JP, Morin S, Leslie W et al (2014) Bisphosphonates for treatment of osteoporosis. Expected benefits, potential harms, and drug holidays. Can Fam Physician 60:324\u2013333","journal-title":"Can Fam Physician"},{"issue":"1","key":"9908_CR35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jbmr.533","volume":"27","author":"JS Sampalis","year":"2012","unstructured":"Sampalis JS, Adachi JD, Rampakakis E et al (2012) Long-term impact of adherence to oral bisphosphonates on osteoporotic fracture incidence. J Bone Miner Res 27(1):202\u2013210","journal-title":"J Bone Miner Res"},{"key":"9908_CR36","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jbmr.1610","volume":"27","author":"B Abrahamsen","year":"2012","unstructured":"Abrahamsen B (2012) Atypical femur fractures: refining the clinical picture. J Bone Miner Res 27:975\u2013976","journal-title":"J Bone Miner Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-014-9908-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-014-9908-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-014-9908-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T07:41:10Z","timestamp":1558683670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-014-9908-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,11]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["9908"],"URL":"https:\/\/doi.org\/10.1007\/s00223-014-9908-x","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,11]]}}}